Clinical Trial Update: Study to Evaluate the Efficacy and Safety of Moxifloxacin Versus Amoxicillin/Clavulanate in the Treatment of Acute Bacterial Rhinosinusitis [Phase 4]

View source ↗

Summary

A Phase 4 randomized trial comparing moxifloxacin to amoxicillin/clavulanate for acute bacterial rhinosinusitis was terminated, with results posted in 2009.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Rhinosinusitis

Drugs mentioned

• Moxifloxacin (moxifloxacin)
• amoxicillin-clavulanate (amoxicillin-clavulanate)

Snippet

Sponsor: Bayer | Conditions: Sinusitis, Bacterial Infections | Phase 4 | Status: TERMINATED | Results posted: 2009-04-13